Navigating the Evolving Landscape of COVID-19: Strategies to Increase Vaccine Confidence and Improve Vaccination Rates in the United States
Open Access
Abstract
The COVID-19 pandemic has had a significant impact on every individual in the United States. The launch of the COVID-19 vaccines is estimated to have averted millions of deaths and reduced over 18 million COVID-19-related hospitalizations. In September 2023, the updated 2023–2024 COVID-19 vaccine, which includes a monovalent component that corresponds to the omicron variant XBB.1.5, reflecting the predominant circulating variant at the time of strain selection, was approved and was recommended for use in all people ≥ 6 months of age. Despite this recommendation, the US uptake of the updated COVID-19 vaccines over the 2023–2024 season has been far from optimal, placing many people at unnecessary risk of severe COVID-19 outcomes. This paper provides an overview of the current state of COVID-19 in 2023–2024 and barriers to vaccine uptake. With the continued evolution of the virus, the potential for more virulent variants, reduced public acceptance of vaccination, and the potential barriers that contributed to low vaccine uptake are explored to provide solutions for improving COVID-19 protection for future seasons.Keywords
All Related Versions
Funding Information
- Moderna, Inc.
This publication has 35 references indexed in Scilit:
- Increase in antibody titer and change over time associated with severe acute respiratory syndrome coronavirus 2 infection after mRNA vaccination: Consideration of the significance of additional vaccinationClinical Case Reports, 2024
- Spatial disparities in the mortality burden of the covid-19 pandemic across 569 European regions (2020-2021)Nature Communications, 2024
- Adverse Events After XBB.1.5-Containing COVID-19 mRNA VaccinesJAMA, 2024
- Inequalities in regional excess mortality and life expectancy during the COVID-19 pandemic in EuropeScientific Reports, 2024
- Amid Health Misinformation, Most Trust Physicians for TruthJAMA, 2023
- Visual policy narrative messaging improves COVID-19 vaccine uptakePNAS Nexus, 2023
- Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic reviewJournal of Infection and Public Health, 2023
- Trusted messengers and trusted messages: The role for community-based organizations in promoting COVID-19 and routine immunizationsVaccine, 2023
- A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccinationVaccine, 2022
- Life expectancy changes since COVID-19Nature Human Behaviour, 2022